NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

O-I Glass Stock: Citi Moves to Buy, Flags Near-Term Catalysts

Citi upgrades O-I Glass to Buy, citing trough valuation levels, a derisked 2026 outlook, and the stock being meaningfully oversold.

O-I Glass Stock: Citi Moves to Buy, Flags Near-Term Catalysts
Photo by Joe Dudeck on Unsplash
Already have an account? Sign in.
08/21/2026 · 6:14 AM
OI
/ Read more

Feed↓

Solid Biosciences and Stoke Therapeutics Get Fresh Bullish Analyst Backing with Big Upside Targets
08/21/2026 · 12:20 PM

Solid Biosciences and Stoke Therapeutics Get Fresh Bullish Analyst Backing with Big Upside Targets

Truist restarts Solid Biosciences at Buy/$20. JPMorgan backs Stoke Therapeutics at Overweight/$40. Cash into 2028.

/ Subscriber only
BMO Capital Starts D-Wave Quantum at Outperform With $35 Target — 86% Upside From Latest Close
Featured/ 08/21/2026 · 11:39 AM

BMO Capital Starts D-Wave Quantum at Outperform With $35 Target — 86% Upside From Latest Close

BMO cites real commercial revenue, a first-mover advantage, and a unique dual annealing-gate technology strategy.

/ Subscriber only
Alvotech Partners with Lotus on Biosimilars to Imfinzi and Hemlibra in the US and Asia
08/21/2026 · 10:14 AM

Alvotech Partners with Lotus on Biosimilars to Imfinzi and Hemlibra in the US and Asia

Alvotech partners with Lotus for biosimilars to Imfinzi and Hemlibra in the US and Asia. Deal worth up to $150M plus ongoing supply revenue.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe